Latest Earnings Results: Q3 '26
Estimated EPS
-$0.27
Reported EPS
-$0.13
Surprise
+52.21%
Estimated Rev
$10.92M
Reported Rev
$9.69M
Surprise
-11.3%
• Reported GAAP EPS of -$0.13 up 67.50% YoY • Reported revenue of $9.69M up 11.51% YoY • electroCore expects the majority of 2026 fiscal year revenue to continue to come from sales of Rx products to the VA; quantified revenue, margin, or earnings guidance was not provided.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | -$0.16 | -- | -- | N/A |
Q3 '26 | -$0.27 | -$0.13 | 52.21% | BEAT |
Q2 '26 | -$0.37 | -$0.33 | 11.07% | BEAT |
Q1 '26 | -$0.61 | -$0.59 | 3.59% | BEAT |
Q4 '25 | -$0.40 | -$0.34 | 15.42% | BEAT |